APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pomalidomide Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Pomalidomide Capsules Industry Growth and Trends Forecast to 2032

27 December 202595 pages

Choose your research edition.

Industry ResearchPomalidomide Capsules Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Pomalidomide Capsules Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Pomalidomide Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pomalidomide Capsules Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Pomalidomide Capsules Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Pomalidomide Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Pomalidomide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Pomalidomide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pomalidomide Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pomalidomide Capsules include Chia Tai Tianqing Pharmaceutical, Qilu Pharmaceutical, Natco Pharma, Hetero, Dr Reddy’s Laboratories, Bristol Myers Squibb, Apotex, Adalvo and Abbott Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Pomalidomide Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Pomalidomide Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Pomalidomide Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Pomalidomide Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Pomalidomide Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Pomalidomide Capsules Market by Company

Chia Tai Tianqing Pharmaceutical

Qilu Pharmaceutical

Natco Pharma

Hetero

Dr Reddy’s Laboratories

Bristol Myers Squibb

Apotex

Adalvo

Abbott Laboratories

Pomalidomide Capsules Segment by Type

1mg per Unit

2mg per Unit

3mg per Unit

4mg per Unit

Pomalidomide Capsules Segment by Application

Kaposi Sarcoma

Multiple Myeloma

Pomalidomide Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pomalidomide Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pomalidomide Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pomalidomide Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pomalidomide Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Pomalidomide Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1mg per Unit Table 2. Major Company of 2mg per Unit Table 3. Major Company of 3mg per Unit Table 4. Major Company of 4mg per Unit Table 5. Global Pomalidomide Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Pomalidomide Capsules Sales by Type (2021-2026) & (K Units) Table 7. Global Pomalidomide Capsules Sales Market Share in Volume by Type (2021-2026) Table 8. Global Pomalidomide Capsules Sales by Type (2021-2026) & (US$ Million) Table 9. Global Pomalidomide Capsules Sales Market Share in Value by Type (2021-2026) Table 10. Global Pomalidomide Capsules Price by Type (2021-2026) & (US$/Unit) Table 11. Global Pomalidomide Capsules Sales by Type (2027-2032) & (K Units) Table 12. Global Pomalidomide Capsules Sales Market Share in Volume by Type (2027-2032) Table 13. Global Pomalidomide Capsules Sales by Type (2027-2032) & (US$ Million) Table 14. Global Pomalidomide Capsules Sales Market Share in Value by Type (2027-2032) Table 15. Global Pomalidomide Capsules Price by Type (2027-2032) & (US$/Unit) Table 16. North America Pomalidomide Capsules Sales by Type (2021-2026) & (K Units) Table 17. North America Pomalidomide Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Pomalidomide Capsules Sales by Type (2021-2026) & (K Units) Table 19. Europe Pomalidomide Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Pomalidomide Capsules Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Pomalidomide Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Pomalidomide Capsules Sales by Type (2021-2026) & (K Units) Table 23. Latin America Pomalidomide Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Pomalidomide Capsules Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Pomalidomide Capsules Sales by Type (2021-2026) & (US$ Million) Table 26. Pomalidomide Capsules Industry Trends Table 27. Pomalidomide Capsules Industry Drivers Table 28. Pomalidomide Capsules Industry Opportunities and Challenges Table 29. Pomalidomide Capsules Industry Restraints Table 30. Global Pomalidomide Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Pomalidomide Capsules Revenue Market Share by Company (2021-2026) Table 32. Global Pomalidomide Capsules Sales by Company (2021-2026) & (K Units) Table 33. Global Pomalidomide Capsules Sales Share by Company (2021-2026) Table 34. Global Pomalidomide Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 35. Global Pomalidomide Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Pomalidomide Capsules Major Company Production Sites and Headquarters Table 37. Global Pomalidomide Capsules Company, Product Type & Application Table 38. Global Pomalidomide Capsules Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Pomalidomide Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Pomalidomide Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Pomalidomide Capsules Sales by Region (2021-2026) & (K Units) Table 43. Global Pomalidomide Capsules Sales Market Share in Volume by Region (2021-2026) Table 44. Global Pomalidomide Capsules Sales by Region (2021-2026) & (US$ Million) Table 45. Global Pomalidomide Capsules Sales Market Share in Value by Region (2021-2026) Table 46. Global Pomalidomide Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 47. Global Pomalidomide Capsules Sales by Region (2027-2032) & (K Units) Table 48. Global Pomalidomide Capsules Sales Market Share in Volume by Region (2027-2032) Table 49. Global Pomalidomide Capsules Sales by Region (2027-2032) & (US$ Million) Table 50. Global Pomalidomide Capsules Sales Market Share in Value by Region (2027-2032) Table 51. Global Pomalidomide Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 52. Global Pomalidomide Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Pomalidomide Capsules Sales by Application (2021-2026) & (K Units) Table 54. Global Pomalidomide Capsules Sales Market Share in Volume by Application (2021-2026) Table 55. Global Pomalidomide Capsules Sales by Application (2021-2026) & (US$ Million) Table 56. Global Pomalidomide Capsules Sales Market Share in Value by Application (2021-2026) Table 57. Global Pomalidomide Capsules Price by Application (2021-2026) & (US$/Unit) Table 58. Global Pomalidomide Capsules Sales by Application (2027-2032) & (K Units) Table 59. Global Pomalidomide Capsules Sales Market Share in Volume by Application (2027-2032) Table 60. Global Pomalidomide Capsules Sales by Application (2027-2032) & (US$ Million) Table 61. Global Pomalidomide Capsules Sales Market Share in Value by Application (2027-2032) Table 62. Global Pomalidomide Capsules Price by Application (2027-2032) & (US$/Unit) Table 63. North America Pomalidomide Capsules Sales by Application (2021-2026) & (K Units) Table 64. North America Pomalidomide Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Pomalidomide Capsules Sales by Application (2021-2026) & (K Units) Table 66. Europe Pomalidomide Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Pomalidomide Capsules Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Pomalidomide Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Pomalidomide Capsules Sales by Application (2021-2026) & (K Units) Table 70. Latin America Pomalidomide Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Pomalidomide Capsules Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Pomalidomide Capsules Sales by Application (2021-2026) & (US$ Million) Table 73. Chia Tai Tianqing Pharmaceutical Company Information Table 74. Chia Tai Tianqing Pharmaceutical Business Overview Table 75. Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Product Portfolio Table 77. Chia Tai Tianqing Pharmaceutical Recent Development Table 78. Qilu Pharmaceutical Company Information Table 79. Qilu Pharmaceutical Business Overview Table 80. Qilu Pharmaceutical Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Qilu Pharmaceutical Pomalidomide Capsules Product Portfolio Table 82. Qilu Pharmaceutical Recent Development Table 83. Natco Pharma Company Information Table 84. Natco Pharma Business Overview Table 85. Natco Pharma Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Natco Pharma Pomalidomide Capsules Product Portfolio Table 87. Natco Pharma Recent Development Table 88. Hetero Company Information Table 89. Hetero Business Overview Table 90. Hetero Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Hetero Pomalidomide Capsules Product Portfolio Table 92. Hetero Recent Development Table 93. Dr Reddy’s Laboratories Company Information Table 94. Dr Reddy’s Laboratories Business Overview Table 95. Dr Reddy’s Laboratories Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Dr Reddy’s Laboratories Pomalidomide Capsules Product Portfolio Table 97. Dr Reddy’s Laboratories Recent Development Table 98. Bristol Myers Squibb Company Information Table 99. Bristol Myers Squibb Business Overview Table 100. Bristol Myers Squibb Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Bristol Myers Squibb Pomalidomide Capsules Product Portfolio Table 102. Bristol Myers Squibb Recent Development Table 103. Apotex Company Information Table 104. Apotex Business Overview Table 105. Apotex Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Apotex Pomalidomide Capsules Product Portfolio Table 107. Apotex Recent Development Table 108. Adalvo Company Information Table 109. Adalvo Business Overview Table 110. Adalvo Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Adalvo Pomalidomide Capsules Product Portfolio Table 112. Adalvo Recent Development Table 113. Abbott Laboratories Company Information Table 114. Abbott Laboratories Business Overview Table 115. Abbott Laboratories Pomalidomide Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Abbott Laboratories Pomalidomide Capsules Product Portfolio Table 117. Abbott Laboratories Recent Development Table 118. North America Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 119. North America Pomalidomide Capsules Sales by Country (2021-2026) & (K Units) Table 120. North America Pomalidomide Capsules Sales Market Share by Country (2021-2026) Table 121. North America Pomalidomide Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 122. North America Pomalidomide Capsules Sales Market Share Forecast by Country (2027-2032) Table 123. North America Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. North America Pomalidomide Capsules Market Size by Country (2021-2026) & (US$ Million) Table 125. North America Pomalidomide Capsules Market Share by Country (2021-2026) Table 126. North America Pomalidomide Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. North America Pomalidomide Capsules Market Share Forecast by Country (2027-2032) Table 128. Europe Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 129. Europe Pomalidomide Capsules Sales by Country (2021-2026) & (K Units) Table 130. Europe Pomalidomide Capsules Sales Market Share by Country (2021-2026) Table 131. Europe Pomalidomide Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 132. Europe Pomalidomide Capsules Sales Market Share Forecast by Country (2027-2032) Table 133. Europe Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Pomalidomide Capsules Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Pomalidomide Capsules Market Share by Country (2021-2026) Table 136. Europe Pomalidomide Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Pomalidomide Capsules Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Pomalidomide Capsules Sales by Country (2021-2026) & (K Units) Table 140. Asia-Pacific Pomalidomide Capsules Sales Market Share by Country (2021-2026) Table 141. Asia-Pacific Pomalidomide Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 142. Asia-Pacific Pomalidomide Capsules Sales Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Pomalidomide Capsules Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Pomalidomide Capsules Market Share by Country (2021-2026) Table 146. Asia-Pacific Pomalidomide Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Pomalidomide Capsules Market Share Forecast by Country (2027-2032) Table 148. Latin America Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 149. Latin America Pomalidomide Capsules Sales by Country (2021-2026) & (K Units) Table 150. Latin America Pomalidomide Capsules Sales Market Share by Country (2021-2026) Table 151. Latin America Pomalidomide Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 152. Latin America Pomalidomide Capsules Sales Market Share Forecast by Country (2027-2032) Table 153. Latin America Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Pomalidomide Capsules Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Pomalidomide Capsules Market Share by Country (2021-2026) Table 156. Latin America Pomalidomide Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Pomalidomide Capsules Market Share Forecast by Country (2027-2032) Table 158. Middle East and Africa Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 159. Middle East and Africa Pomalidomide Capsules Sales by Country (2021-2026) & (K Units) Table 160. Middle East and Africa Pomalidomide Capsules Sales Market Share by Country (2021-2026) Table 161. Middle East and Africa Pomalidomide Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 162. Middle East and Africa Pomalidomide Capsules Sales Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Pomalidomide Capsules Market Size by Country (2021-2026) & (US$ Million) Table 165. Middle East and Africa Pomalidomide Capsules Market Share by Country (2021-2026) Table 166. Middle East and Africa Pomalidomide Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Middle East and Africa Pomalidomide Capsules Market Share Forecast by Country (2027-2032) Table 168. Key Raw Materials Table 169. Raw Materials Key Suppliers Table 170. Pomalidomide Capsules Distributors List Table 171. Pomalidomide Capsules Customers List Table 172. Research Programs/Design for This Report Table 173. Authors List of This Report Table 174. Secondary Sources Table 175. Primary Sources List of Figures Figure 1. Pomalidomide Capsules Image Figure 2. Global Pomalidomide Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pomalidomide Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Pomalidomide Capsules Sales (2021-2032) & (K Units) Figure 5. 1mg per Unit Image Figure 6. Global 1mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 7. 2mg per Unit Image Figure 8. Global 2mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 9. 3mg per Unit Image Figure 10. Global 3mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 11. 4mg per Unit Image Figure 12. Global 4mg per Unit Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Pomalidomide Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Pomalidomide Capsules Market Share by Type 2025 VS 2032 Figure 15. North America Pomalidomide Capsules Sales Market Share in Volume by Type in 2025 Figure 16. North America Pomalidomide Capsules Sales Market Share in Value by Type in 2025 Figure 17. Europe Pomalidomide Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Europe Pomalidomide Capsules Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Pomalidomide Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Pomalidomide Capsules Sales Market Share in Value by Type in 2025 Figure 21. Latin America Pomalidomide Capsules Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Pomalidomide Capsules Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Pomalidomide Capsules Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Pomalidomide Capsules Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Pomalidomide Capsules Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Kaposi Sarcoma Image Figure 28. Global Kaposi Sarcoma Sales YoY Growth (2021-2032) & (K Units) Figure 29. Multiple Myeloma Image Figure 30. Global Multiple Myeloma Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Pomalidomide Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Pomalidomide Capsules Market Share by Application 2025 VS 2032 Figure 33. North America Pomalidomide Capsules Sales Market Share in Volume by Application in 2025 Figure 34. North America Pomalidomide Capsules Sales Market Share in Value by Application in 2025 Figure 35. Europe Pomalidomide Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Europe Pomalidomide Capsules Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Pomalidomide Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Pomalidomide Capsules Sales Market Share in Value by Application in 2025 Figure 39. Latin America Pomalidomide Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Pomalidomide Capsules Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Pomalidomide Capsules Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Pomalidomide Capsules Sales Market Share in Value by Application in 2025 Figure 43. North America Pomalidomide Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Pomalidomide Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Pomalidomide Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Pomalidomide Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Pomalidomide Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Pomalidomide Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Pomalidomide Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Pomalidomide Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Pomalidomide Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Pomalidomide Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Pomalidomide Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Pomalidomide Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Pomalidomide Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Pomalidomide Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Pomalidomide Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Pomalidomide Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Pomalidomide Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Pomalidomide Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Pomalidomide Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Pomalidomide Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Pomalidomide Capsules Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Pomalidomide Capsules Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg per Unit
  • 2mg per Unit
  • 3mg per Unit
  • 4mg per Unit
Applications
  • Kaposi Sarcoma
  • Multiple Myeloma
Companies covered
  • Chia Tai Tianqing Pharmaceutical
  • Qilu Pharmaceutical
  • Natco Pharma
  • Hetero
  • Dr Reddy’s Laboratories
  • Bristol Myers Squibb
  • Apotex
  • Adalvo
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Pomalidomide Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Pomalidomide Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Pomalidomide Capsules Market by Type
  6. 1.3.1 1mg per Unit
  7. 1.3.2 2mg per Unit
  8. 1.3.3 3mg per Unit
  9. 1.3.4 4mg per Unit
  10. 1.4 Global Pomalidomide Capsules Market Size by Type
  11. 1.4.1 Global Pomalidomide Capsules Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Pomalidomide Capsules Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Pomalidomide Capsules Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Pomalidomide Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Pomalidomide Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Pomalidomide Capsules Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Pomalidomide Capsules Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Pomalidomide Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Pomalidomide Capsules Industry Trends
  2. 2.2 Pomalidomide Capsules Industry Drivers
  3. 2.3 Pomalidomide Capsules Industry Opportunities and Challenges
  4. 2.4 Pomalidomide Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Pomalidomide Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Pomalidomide Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Pomalidomide Capsules Price (2021-2026)
  4. 3.4 Global Pomalidomide Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pomalidomide Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Pomalidomide Capsules Company, Product Type & Application
  7. 3.7 Global Pomalidomide Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pomalidomide Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pomalidomide Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pomalidomide Capsules Tier 1, Tier 2, and Tier 3
4 Pomalidomide Capsules Regional Status and Outlook
  1. 4.1 Global Pomalidomide Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Pomalidomide Capsules Historic Market Size by Region
  3. 4.2.1 Global Pomalidomide Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Pomalidomide Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Pomalidomide Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Pomalidomide Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Pomalidomide Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Pomalidomide Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Pomalidomide Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Pomalidomide Capsules by Application
  1. 5.1 Pomalidomide Capsules Market by Application
  2. 5.1.1 Kaposi Sarcoma
  3. 5.1.2 Multiple Myeloma
  4. 5.2 Global Pomalidomide Capsules Market Size by Application
  5. 5.2.1 Global Pomalidomide Capsules Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Pomalidomide Capsules Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Pomalidomide Capsules Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Pomalidomide Capsules Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Pomalidomide Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Pomalidomide Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Pomalidomide Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Pomalidomide Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chia Tai Tianqing Pharmaceutical
  2. 6.1.1 Chia Tai Tianqing Pharmaceutical Company Information
  3. 6.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
  4. 6.1.3 Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chia Tai Tianqing Pharmaceutical Pomalidomide Capsules Product Portfolio
  6. 6.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
  7. 6.2 Qilu Pharmaceutical
  8. 6.2.1 Qilu Pharmaceutical Company Information
  9. 6.2.2 Qilu Pharmaceutical Business Overview
  10. 6.2.3 Qilu Pharmaceutical Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Qilu Pharmaceutical Pomalidomide Capsules Product Portfolio
  12. 6.2.5 Qilu Pharmaceutical Recent Developments
  13. 6.3 Natco Pharma
  14. 6.3.1 Natco Pharma Company Information
  15. 6.3.2 Natco Pharma Business Overview
  16. 6.3.3 Natco Pharma Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Natco Pharma Pomalidomide Capsules Product Portfolio
  18. 6.3.5 Natco Pharma Recent Developments
  19. 6.4 Hetero
  20. 6.4.1 Hetero Company Information
  21. 6.4.2 Hetero Business Overview
  22. 6.4.3 Hetero Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hetero Pomalidomide Capsules Product Portfolio
  24. 6.4.5 Hetero Recent Developments
  25. 6.5 Dr Reddy’s Laboratories
  26. 6.5.1 Dr Reddy’s Laboratories Company Information
  27. 6.5.2 Dr Reddy’s Laboratories Business Overview
  28. 6.5.3 Dr Reddy’s Laboratories Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dr Reddy’s Laboratories Pomalidomide Capsules Product Portfolio
  30. 6.5.5 Dr Reddy’s Laboratories Recent Developments
  31. 6.6 Bristol Myers Squibb
  32. 6.6.1 Bristol Myers Squibb Company Information
  33. 6.6.2 Bristol Myers Squibb Business Overview
  34. 6.6.3 Bristol Myers Squibb Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bristol Myers Squibb Pomalidomide Capsules Product Portfolio
  36. 6.6.5 Bristol Myers Squibb Recent Developments
  37. 6.7 Apotex
  38. 6.7.1 Apotex Company Information
  39. 6.7.2 Apotex Business Overview
  40. 6.7.3 Apotex Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Apotex Pomalidomide Capsules Product Portfolio
  42. 6.7.5 Apotex Recent Developments
  43. 6.8 Adalvo
  44. 6.8.1 Adalvo Company Information
  45. 6.8.2 Adalvo Business Overview
  46. 6.8.3 Adalvo Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Adalvo Pomalidomide Capsules Product Portfolio
  48. 6.8.5 Adalvo Recent Developments
  49. 6.9 Abbott Laboratories
  50. 6.9.1 Abbott Laboratories Company Information
  51. 6.9.2 Abbott Laboratories Business Overview
  52. 6.9.3 Abbott Laboratories Pomalidomide Capsules Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Abbott Laboratories Pomalidomide Capsules Product Portfolio
  54. 6.9.5 Abbott Laboratories Recent Developments
7 North America by Country
  1. 7.1 North America Pomalidomide Capsules Sales by Country
  2. 7.1.1 North America Pomalidomide Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Pomalidomide Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Pomalidomide Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Pomalidomide Capsules Market Size by Country
  6. 7.2.1 North America Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Pomalidomide Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Pomalidomide Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Pomalidomide Capsules Sales by Country
  2. 8.1.1 Europe Pomalidomide Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Pomalidomide Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Pomalidomide Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Pomalidomide Capsules Market Size by Country
  6. 8.2.1 Europe Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Pomalidomide Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Pomalidomide Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Pomalidomide Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Pomalidomide Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Pomalidomide Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Pomalidomide Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Pomalidomide Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Pomalidomide Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Pomalidomide Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Pomalidomide Capsules Sales by Country
  2. 10.1.1 South America Pomalidomide Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Pomalidomide Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Pomalidomide Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Pomalidomide Capsules Market Size by Country
  6. 10.2.1 South America Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Pomalidomide Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Pomalidomide Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Pomalidomide Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Pomalidomide Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Pomalidomide Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Pomalidomide Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Pomalidomide Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Pomalidomide Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Pomalidomide Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Pomalidomide Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Pomalidomide Capsules Value Chain Analysis
  2. 12.1.1 Pomalidomide Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Pomalidomide Capsules Production Mode & Process
  7. 12.2 Pomalidomide Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Pomalidomide Capsules Distributors
  10. 12.2.3 Pomalidomide Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst